Tag: Mosunetuzumab

Clinically meaningful outcomes for mosunetuzumab across follicular lymphoma subgroups

Presented By
Dr Sarit Assouline, Jewish General Hospital, Canada
Trial
Phase 1/2
Conference
EHA 2024
Type
Peer-reviewed article

12 August 2024 14:26

Primary phase 2 efficacy and safety results of M-Pola in relapsed/refractory LBCL

Presented By
Dr Elizabeth Budde, City of Hope National Medical Center, CA, USA
Trial
Phase 1/2
Conference
ASH 2023
Type
Peer-reviewed article

7 February 2024 14:59

Mosunetuzumab: complete remissions in non-Hodgkin lymphoma

Presented By
Prof. Stephen Schuster, University of Pennsylvania, USA
Conference
ASH 2019
Type
Peer-reviewed article

5 March 2020 09:50
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com